Photo of Elad Sharon from American Association for Cancer Research
Feb 23, 2024, 17:26
Elad Sharon: Honored to receive a plaque for our team’s work getting the first immune checkpoint inhibitor approved in sarcoma!
Elad Sharon, Medical Oncologist at Dana-Farber Cancer Institute, made the following post on X:
“Honored to receive a plaque for our team’s work getting the first immune checkpoint inhibitor approved in sarcoma! Alveolar Soft Part Sarcoma is a rare cancer! Thanks for this NIH Director’s award! My last for work I did NCI CTEP Clinical Research! Thanks to National Institutes of Health, Genentech & FDA Oncology.”
Source: Elad Sharon/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 22, 2025, 05:18
Feb 22, 2025, 05:15
Feb 22, 2025, 05:05
Feb 22, 2025, 04:54
Feb 22, 2025, 04:49
Feb 22, 2025, 04:33
Feb 22, 2025, 04:29